Windtree Therapeutics - Warrants (25/03/2026) (WINT+) Q2 2022 Earnings

11AugExpected
Q3 2021
Q4 2021
Q1 2022
Q2 2022
-26
-20.33
-14.67
-9

Details

Expected EPS
-9
Actual EPS
-10
Surprise EPS
-1
Surprise Percent
+11.11%

Description

Windtree Therapeutics - Warrants (25/03/2026) (WINT+) has reported earnings of -10 per share for Q2 2022.

0 Comments

Share your thoughts